DYAI: Dyadic International Inc. Stocks News on April 2, 2025

Dyadic International Full Year 2024 Earnings: Misses Expectations

DYAI

Simply Wall St.

5 days ago

Dyadic International Full Year 2024 Earnings: Misses Expectations

DYAI

Zacks Small Cap Research

6 days ago

DYAI: CEPI Grants Recognize C1

DYAI

Thomson Reuters StreetEvents

6 days ago

Q4 2024 Dyadic International Inc Earnings Call

DYAI

GuruFocus.com

6 days ago

Dyadic International Inc (DYAI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

Dyadic Reports 2024 Year-End Financial Results and Business Updates

DYAI

GlobeNewswire

7 days ago

Dyadic Reports 2024 Year-End Financial Results and Business Updates

DYAI

GuruFocus.com

8 days ago

What To Expect From Dyadic International Inc (DYAI) Q4 2024 Earnings

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

DYAI

GlobeNewswire

13 days ago

Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

DYAI

GlobeNewswire

21 days ago

Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Dyadic to Attend Multiple Industry Events in March

DYAI

GlobeNewswire

a month ago

Dyadic to Attend Multiple Industry Events in March

3 US Penny Stocks With Market Caps Over $40M To Consider

DYAI

Simply Wall St.

2 months ago

3 US Penny Stocks With Market Caps Over $40M To Consider

DYAI

Zacks Small Cap Research

2 months ago

DYAI: Looking Toward Product Revenues

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

DYAI

GlobeNewswire

3 months ago

Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference

Dyadic International And 2 Other US Penny Stocks To Watch

DYAI

Simply Wall St.

3 months ago

Dyadic International And 2 Other US Penny Stocks To Watch

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

DYAI

GlobeNewswire

4 months ago

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Top US Penny Stocks To Watch In November 2024

DYAI

Simply Wall St.

4 months ago

Top US Penny Stocks To Watch In November 2024

Dyadic International Third Quarter 2024 Earnings: Beats Expectations

DYAI

Simply Wall St.

5 months ago

Dyadic International Third Quarter 2024 Earnings: Beats Expectations

DYAI

Zacks Small Cap Research

5 months ago

DYAI: Milestones Achieved; Product Revenues Next?

DYAI

GuruFocus.com

5 months ago

Dyadic International Inc (DYAI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

DYAI

GlobeNewswire

5 months ago

Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets

DYAI

GuruFocus.com

5 months ago

Earnings To Watch: Dyadic International Inc (DYAI) Reports Q3 2024 Result

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

DYAI

GlobeNewswire

5 months ago

Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

DYAI

GuruFocus.com

6 months ago

Dyadic International Inc (DYAI) Q2 2024 Earnings Call Highlights: Strategic Positioning Amid ...

Dyadic Expands Global Presence with Participation in Key Industry Events

DYAI

GlobeNewswire

6 months ago

Dyadic Expands Global Presence with Participation in Key Industry Events

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

DYAI

GlobeNewswire

6 months ago

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference

DYAI

Zacks Small Cap Research

7 months ago

DYAI: Product Revenues Next Year

Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

DYAI

GlobeNewswire

8 months ago

Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

DYAI

GlobeNewswire

8 months ago

Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024

DYAI

Zacks Small Cap Research

9 months ago

DYAI: Moo-ve Over Bovines, C1's Taking On Albumin

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

DYAI

GlobeNewswire

9 months ago

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

Dyadic to Attend Industry Events in June

DYAI

GlobeNewswire

10 months ago

Dyadic to Attend Industry Events in June

DYAI

GuruFocus.com

a year ago

Dyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review ...

DYAI

Zacks Small Cap Research

a year ago

DYAI: Product Revenues Next Year

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

DYAI

GlobeNewswire

a year ago

Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Dyadic to Attend Industry and Investor Events in May

DYAI

GlobeNewswire

a year ago

Dyadic to Attend Industry and Investor Events in May

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

DYAI

GlobeNewswire

a year ago

Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024

DYAI

Insider Monkey

a year ago

Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript

DYAI

Zacks Small Cap Research

a year ago

DYAI: Capital Raise to Accelerate Near Term Revenue Growth

DYAI

Thomson Reuters StreetEvents

a year ago

Q4 2023 Dyadic International Inc Earnings Call

Dyadic Reports 2023 Full Year Results and Recent Company Progress

DYAI

GlobeNewswire

a year ago

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Dyadic Announces Change in Board and Management Leadership Roles

DYAI

GlobeNewswire

a year ago

Dyadic Announces Change in Board and Management Leadership Roles

Dyadic to Attend Industry Events in April

DYAI

GlobeNewswire

a year ago

Dyadic to Attend Industry Events in April

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

DYAI

GlobeNewswire

a year ago

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

DYAI

GlobeNewswire

a year ago

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

DYAI

GlobeNewswire

a year ago

Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

DYAI

GlobeNewswire

a year ago

CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

DYAI

GlobeNewswire

a year ago

Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization

Dyadic to Attend Industry Events in March

DYAI

GlobeNewswire

a year ago

Dyadic to Attend Industry Events in March

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

DYAI

GlobeNewswire

a year ago

Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

DYAI

GlobeNewswire

a year ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

DYAI

GlobeNewswire

a year ago

Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

DYAI

Zacks Small Cap Research

a year ago

DYAI: Catching Up With Dyadic

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

DYAI

GlobeNewswire

a year ago

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company

DYAI

GlobeNewswire

a year ago

Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company

Dyadic to Attend BIO CEO & Investor Conference and European Industry Events

DYAI

GlobeNewswire

a year ago

Dyadic to Attend BIO CEO & Investor Conference and European Industry Events

FS Bancorp (NASDAQ:FSBW) Is Increasing Its Dividend To $0.26

DYAI

Simply Wall St.

a year ago

FS Bancorp (NASDAQ:FSBW) Is Increasing Its Dividend To $0.26

First US Bancshares Full Year 2023 Earnings: EPS: US$1.42 (vs US$1.13 in FY 2022)

DYAI

Simply Wall St.

a year ago

First US Bancshares Full Year 2023 Earnings: EPS: US$1.42 (vs US$1.13 in FY 2022)

DYAI

Associated Press Finance

a year ago

Peoples Financial Services: Q4 Earnings Snapshot

United Security Bancshares (UBFO) Reports Record Net Income for 2023

DYAI

GuruFocus.com

a year ago

United Security Bancshares (UBFO) Reports Record Net Income for 2023

PEOPLES FINANCIAL SERVICES CORP. Reports Unaudited Fourth Quarter and Year to Date 2023 Earnings

DYAI

PR Newswire

a year ago

PEOPLES FINANCIAL SERVICES CORP. Reports Unaudited Fourth Quarter and Year to Date 2023 Earnings

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

DYAI

Simply Wall St.

a year ago

Eton Pharmaceuticals (NASDAQ:ETON) investors are sitting on a loss of 50% if they invested three years ago

DYAI

Newsfile

a year ago

Dyadic International, Inc Invites You to Join Us at The Microcap Conference

Landmark Bancorp, Inc. Announces Conference Call to Discuss Fourth Quarter 2023 Earnings

DYAI

GlobeNewswire

a year ago

Landmark Bancorp, Inc. Announces Conference Call to Discuss Fourth Quarter 2023 Earnings

DZS Extends Partnership with Andorix to Transform the Infrastructure and Commercial Management Economics of Historical Landmarks

DYAI

GlobeNewswire

a year ago

DZS Extends Partnership with Andorix to Transform the Infrastructure and Commercial Management Economics of Historical Landmarks

Specialty Retail Stocks Q3 Highlights: Academy Sports (NASDAQ:ASO)

DYAI

StockStory

a year ago

Specialty Retail Stocks Q3 Highlights: Academy Sports (NASDAQ:ASO)

Institutional investors may adopt severe steps after Magnachip Semiconductor Corporation's (NYSE:MX) latest 10% drop adds to a year losses

DYAI

Simply Wall St.

a year ago

Institutional investors may adopt severe steps after Magnachip Semiconductor Corporation's (NYSE:MX) latest 10% drop adds to a year losses

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

DYAI

GlobeNewswire

a year ago

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

DYAI

Market Exclusive

a year ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Eltek (NASDAQ:ELTK) Is Very Good At Capital Allocation

DYAI

Simply Wall St.

a year ago

Eltek (NASDAQ:ELTK) Is Very Good At Capital Allocation

Urban Farming Frontiers: 3 Stocks Growing Greens in the City

DYAI

InvestorPlace

a year ago

Urban Farming Frontiers: 3 Stocks Growing Greens in the City

IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals

DYAI

GlobeNewswire

a year ago

IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals

We Like Ituran Location and Control's (NASDAQ:ITRN) Returns And Here's How They're Trending

DYAI

Simply Wall St.

a year ago

We Like Ituran Location and Control's (NASDAQ:ITRN) Returns And Here's How They're Trending

Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference

DYAI

GlobeNewswire

a year ago

Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

DYAI

GlobeNewswire

a year ago

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

Not Many Are Piling Into P3 Health Partners Inc. (NASDAQ:PIII) Just Yet

DYAI

Simply Wall St.

a year ago

Not Many Are Piling Into P3 Health Partners Inc. (NASDAQ:PIII) Just Yet

Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System

DYAI

PR Newswire

a year ago

Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System

Epsilon Energy Ltd.'s (NASDAQ:EPSN) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

DYAI

Simply Wall St.

a year ago

Epsilon Energy Ltd.'s (NASDAQ:EPSN) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Dyadic Attends Investor Events in December

DYAI

GlobeNewswire

a year ago

Dyadic Attends Investor Events in December

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

DYAI

GlobeNewswire

a year ago

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

DYAI

GlobeNewswire

a year ago

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate

Perma-Fix Joint Venture Receives Notice of Intent to Award European Waste Treatment Contract Valued at up to EUR 50 Million

DYAI

GlobeNewswire

a year ago

Perma-Fix Joint Venture Receives Notice of Intent to Award European Waste Treatment Contract Valued at up to EUR 50 Million

DYAI

Simply Wall St.

a year ago

Shareholders in Dyadic International (NASDAQ:DYAI) are in the red if they invested three years ago

Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa

DYAI

GlobeNewswire

a year ago

Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa

Low-Priced Office REITs Are On Fire This Week

DYAI

Benzinga

a year ago

Low-Priced Office REITs Are On Fire This Week

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)

DYAI

Zacks

a year ago

Down -84.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Aclaris (ACRS)

VIZSLA SILVER IS HONORED TO WELCOME MINING HALL OF FAME MEMBER EDUARDO LUNA TO ITS BOARD OF DIRECTORS

DYAI

CNW Group

a year ago

VIZSLA SILVER IS HONORED TO WELCOME MINING HALL OF FAME MEMBER EDUARDO LUNA TO ITS BOARD OF DIRECTORS

Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

DYAI

GlobeNewswire

a year ago

Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Allot to Release Third Quarter 2023 Earnings on November 16, 2023 and Reschedules Conference Call to November 22, 2023

DYAI

GlobeNewswire

a year ago

Allot to Release Third Quarter 2023 Earnings on November 16, 2023 and Reschedules Conference Call to November 22, 2023

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

DYAI

Insider Monkey

a year ago

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

DYAI

Business Wire

a year ago

OppFi Reports Third Quarter 2023 Results, Raises Full-Year Earnings Outlook

DYAI

Insider Monkey

a year ago

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

DYAI

GlobeNewswire

a year ago

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

Why The ONE Group (STKS) Shares Are Sliding Today

DYAI

StockStory

a year ago

Why The ONE Group (STKS) Shares Are Sliding Today

Oportun to cut 185 jobs, end Sezzle partnership

DYAI

Banking Dive

a year ago

Oportun to cut 185 jobs, end Sezzle partnership

The One Group Hospitality Inc (STKS) Reports Mixed Third Quarter 2023 Results Amid Expansion Efforts

DYAI

GuruFocus.com

a year ago

The One Group Hospitality Inc (STKS) Reports Mixed Third Quarter 2023 Results Amid Expansion Efforts

DYAI

PR Newswire

a year ago

Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare Conference

Upland Software, Inc. (NASDAQ:UPLD) Q3 2023 Earnings Call Transcript

DYAI

Insider Monkey

a year ago

Upland Software, Inc. (NASDAQ:UPLD) Q3 2023 Earnings Call Transcript

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of October 31, 2023

DYAI

ACCESSWIRE

a year ago

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of October 31, 2023

FNCB Bancorp, Inc. Announces Third Quarter 2023 Results

DYAI

GlobeNewswire

a year ago

Latest Dyadic International Inc. (DYAI) News on April 2, 2025

Share on Social Networks: